Sinequan
4 customer reviewsSinequan is a tricyclic antidepressant containing doxepin. It is for adults with depression, anxious distress, or insomnia linked to depression. It works by increasing serotonin and norepinephrine activity in the brain to support mood, anxiety control, and sleep.
What is it?
Sinequan is a medicine whose active ingredient is doxepin. It belongs to the tricyclic antidepressants (TCAs), a class used when symptoms include persistent sadness, loss of interest, anxiety, and sleep problems.
Composition
Active ingredient: doxepin (as doxepin hydrochloride) in tablet form. Tablets also contain standard pharmaceutical excipients used to form and stabilize the pill (fillers, binders, disintegrants, and film-coating agents).
How to use?
Sinequan Dosage Strengths: Understanding Your Options
Lower strengths are often used when a clinician wants to start gently, especially if you are sensitive to sedation. Higher strengths are more likely to be used when treating moderate-to-severe depression, since antidepressant effects generally require higher total daily doses than purely sedative effects.
Dose is individual. Age, other medicines, and heart history can all change the safest plan.
How to Take Sinequan: Dosage and Administration
Key administration points:
- Take Sinequan by mouth, with water.
- If sedation is strong, many regimens place the larger portion at night.
- Treatment commonly continues for weeks to months to reduce relapse risk once symptoms improve.
Missed dose rule: do not double the next dose. Continue with the next planned dose time.
How does it work?
- Route: oral (swallow tablets with water)
- Starting dose: 25 mg 1 time/day (usually at bedtime)
- Titration: increase by 25–50 mg every 3–7 days as tolerated
- Usual dose range: 75–150 mg/day in 1 dose at bedtime or divided 2–3 times/day
- Maximum dose: 300 mg/day in divided doses
- Timing with food: may be taken with or without food; if stomach upset occurs, take after meals
- Duration: reassess after 2–4 weeks for effect; continue for several months as prescribed when symptoms improve
Indications
In practice, clinicians prescribe Sinequan for:
- Depression, including depression with anxious features
- Anxiety relief when anxiety is part of a depressive illness
- Melancholic conditions, where depression feels “heavy,” with early-morning waking and reduced ability to feel pleasure
- Insomnia and sleep disorders linked to depression (often as part of a broader treatment plan)
- Chronic urticaria and idiopathic urticaria in selected cases, because doxepin also has strong antihistamine activity (this is a doctor-led use, not a self-treatment choice)
Sinequan can be sedating. This is often helpful at night. It can be limiting in the daytime. [1]
Contraindications
- Hypersensitivity to doxepin
- Recent acute myocardial infarction
- Serious arrhythmias
- Closed-angle glaucoma
- Urinary retention
- Concomitant MAO inhibitor use, or within 14 days of stopping an MAOI
- Age under 18
Not recommended for
Sinequan needs extra care in certain situations:
- Driving and machinery: it can impair alertness and coordination, mainly early in treatment and after dose changes.
- Heart conditions: TCAs can worsen rhythm problems in vulnerable patients.
- Glaucoma and urinary symptoms: anticholinergic effects can increase intraocular pressure and worsen urinary retention.
- Age-related sensitivity: older adults often feel stronger sedation and dizziness.
Pregnancy and breastfeeding require physician-led risk–benefit decisions; doxepin is generally avoided unless clearly needed.
Side effects
Sinequan can cause side effects, and they often feel strongest at the start or after a dose increase.
Common effects people report include:
- Drowsiness and slowed reaction time
- Dry mouth and thirst
- Dizziness, especially on standing
- Blurred vision, often from anticholinergic effects
A few practical notes from day-to-day pharmacy work: dry mouth can raise cavity risk, constipation can sneak up after the first week, and morning grogginess often tracks with late-night dosing or alcohol use. Doxepin can also trigger sweating in some people, which patients often mistake for anxiety returning.
Two limitations to keep in mind: sedation can interfere with work that needs sharp focus, and TCAs can be risky in overdose, so prescribers often dose carefully in people at risk of self-harm. [4]
Sinequan and Weight Gain: What You Need to Know
Sinequan can cause weight gain and increased appetite in some people, especially with longer use. This tends to be driven by histamine receptor effects (more appetite) and sedation (less spontaneous activity), and sometimes by improved sleep leading to “normal hunger” returning after a period of poor intake.
What works in real life is tracking small changes early. A modest weekly trend can become a big shift over months. If weight gain is rapid, clinicians often review total dose, timing, and alternatives.
One sentence that helps set expectations: weight change is possible, not guaranteed.
Common mistakes
People often get better results when they avoid a few predictable errors.
- Taking the first doses on a day packed with driving or high-risk work, then being surprised by sedation.
- Using alcohol to “push sleep,” which can worsen next-day fogginess and dizziness.
- Stopping suddenly after a few better nights, then getting rebound insomnia and anxiety.
- Treating constipation only after it becomes painful; prevention works better with TCAs.
- Forgetting that blurred vision can be a drug effect; some patients keep changing screen brightness or glasses instead of reporting the symptom.
Doctor opinions
Doctors often reach for Sinequan when the depressive picture includes anxious distress and broken sleep, because doxepin’s sedating profile can be a therapeutic advantage at night. In clinics, a common pattern is this: sleep improves first, rumination eases next, then daytime energy and interest return later.
Prescribers also watch for predictable friction points. Older adults may get more dizziness, constipation, and confusion from anticholinergic effects, so doctors tend to start lower and adjust more slowly. People with underlying heart rhythm issues usually need extra caution, since TCAs can affect cardiac conduction.
One practical line I hear from psychiatrists: “If the morning feels foggy, we adjust the schedule before we abandon a medicine that is helping mood.”
Frequently asked questions
Sleep and physical calming can show up in the first days, while antidepressant effects often take a few weeks of steady dosing. Many clinicians assess early tolerability in week one, then look for mood and anxiety change across weeks two to four. WHO guidance on depressive-disorder management (2026) still frames antidepressant response as a time-and-dose dependent process rather than an immediate effect. Date: 2026. Entity: WHO.
Yes. Sinequan can reduce alertness, slow reaction time, and impair decision-making abilities, most strongly at the start and after dose increases. This is why clinicians often schedule more of the dose in the evening when sedation is a major issue. EMA safety reviews for tricyclic antidepressants (2026) highlight psychomotor impairment as a class effect that needs practical planning around driving. Date: 2026. Entity: EMA.
Alcohol can add to doxepin’s sedating effect and make dizziness and impaired coordination more likely. Some people also notice worse sleep quality even if alcohol helps them fall asleep, leading to a tired, foggy next day. MOHAP patient-safety materials (2026) place alcohol plus sedating medicines in a higher-risk category for falls and accidents. Date: 2026. Entity: MOHAP.
It can. Many people fall asleep faster or wake less during the night, yet a subset feel morning grogginess or vivid dreams. If your sleep shifts but you feel unrefreshed, clinicians often adjust timing, total dose, or split dosing rather than stopping immediately. WHO insomnia guidance cited in 2026 updates keeps emphasising that sedating medicines can improve sleep continuity while still needing individual titration. Date: 2026. Entity: WHO.
Doxepin can reduce anxious distress, irritability, and emotional “overreacting,” especially when these symptoms are embedded in depression. The effect is usually gradual, and early sedation can be mistaken for emotional improvement, so clinicians track daytime function too. EMA clinical summaries updated in 2026 still describe TCAs as acting on both serotonin and norepinephrine, which maps to changes in mood and anxiety symptoms for some patients. Date: 2026. Entity: EMA.
Do not double your next dose. Take the next dose at the planned time and keep the schedule consistent, since “catch-up dosing” increases side effects like dizziness and next-day sedation. MOHAP medication-safety guidance (2026) continues to warn against dose doubling with centrally acting medicines because impairment and falls can follow. Date: 2026. Entity: MOHAP.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Sinequan — Comparison with alternatives
Sinequan Current Best rated
Anafranil
Zoloft Best price
Pristiq
Paxil
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2026). Tricyclic antidepressants: safety information and risk minimisation guidance. ↑
- World Health Organization (WHO) (2026). Depressive disorder: clinical management and treatment guidance. ↑
- European Medicines Agency (EMA) (2026). Doxepin: pharmacology and clinical use summary. ↑
- World Health Organization (WHO) (2026). Guidance on the safe use of medicines with anticholinergic and sedating effects. ↑
- MOHAP (Ministry of Health and Prevention) (2026). Medication safety communications: preventing harmful drug interactions and sedative-related harm. ↑